From the Research
The recommended dosage for CJC1295 with Ipamorelin is typically 200-300 mcg of each peptide, administered via subcutaneous injection once daily, preferably before bedtime. This combination is usually taken 5 days on, 2 days off, or every day for 8-12 weeks followed by a 4-week break before resuming. For administration, use insulin syringes (29-31 gauge) and inject into areas with subcutaneous fat such as the abdomen, thigh, or love handles. Reconstitute the lyophilized peptides with bacteriostatic water, store in the refrigerator, and avoid shaking the vial. These peptides work synergistically - CJC1295 extends the half-life of growth hormone releasing hormone while Ipamorelin stimulates growth hormone release without affecting cortisol or prolactin levels. This combination helps optimize natural growth hormone production, potentially improving recovery, lean muscle mass, fat loss, and sleep quality. Side effects may include water retention, tingling, headaches, or injection site reactions. It's essential to consult with a healthcare provider before starting this regimen as individual needs may vary.
Key Considerations
- The dosage of CJC1295 and Ipamorelin may vary depending on individual needs and health status, as noted in studies such as 1 and 2.
- The combination of CJC1295 and Ipamorelin has been shown to be effective in stimulating growth hormone release and improving growth rates, as demonstrated in studies such as 3 and 2.
- The administration of CJC1295 and Ipamorelin should be done under the guidance of a healthcare provider, as they can help monitor for potential side effects and adjust the dosage as needed.
Administration and Storage
- Use insulin syringes (29-31 gauge) for administration
- Inject into areas with subcutaneous fat such as the abdomen, thigh, or love handles
- Reconstitute the lyophilized peptides with bacteriostatic water
- Store in the refrigerator and avoid shaking the vial